These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 8470043
21. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A. Mukai S, Nagata K, Ikeda M, Arai S, Sugano M, Honda T, Okumura N. Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696 [Abstract] [Full Text] [Related]
22. Novel fibrinogen Aalpha chain mutation associated with afibrinogenaemia. Saravanan L, Brennan S, George P, Lowen R, Kirkland M, Campbell P. Pathology; 2007 Oct; 39(5):519-20. PubMed ID: 17886104 [No Abstract] [Full Text] [Related]
23. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release. Mathonnet F, Guillon L, Detruit H, Mazmanian GM, Dreyfus M, Alvarez JC, Giudicelli Y, de Mazancourt P. Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754 [Abstract] [Full Text] [Related]
30. A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution. Zhou N, Xu P, Zhou M, Xu Y, Li P, Chen B, Ouyang J, Zhou R. J Thromb Thrombolysis; 2017 Jul; 44(1):139-144. PubMed ID: 28425010 [Abstract] [Full Text] [Related]
31. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain]. Devignes J, Hanss M, Chabaud A, Toussaint-Hacquard M, Mansuy L, De Mazancourt P, Lecompte T. Ann Biol Clin (Paris); 2013 Jul; 71(4):489-95. PubMed ID: 23906582 [Abstract] [Full Text] [Related]
35. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations. Brennan SO, Fellowes AP, Faed JM, George PM. Blood; 2000 Mar 01; 95(5):1709-13. PubMed ID: 10688828 [Abstract] [Full Text] [Related]